In this issue:
Host-microbe interactions and disease severity in psoriatic skin
Air pollution and genetic susceptibility in psoriasis
Work and activity in IBD and other autoimmune conditions
Clinical characteristics and response to biologics
Circulating monocytes predict apremilast response in plaque psoriasis
Ustekinumab biosimilar for moderate-to-severe plaque psoriasis
Plaque psoriasis relapse after secukinumab withdrawal
Secukinumab and deep resolution of inflammatory markers of psoriasis
Efficacy and safety of bimekizumab in elderly patients
Psoriasis and anti-neoplastic agents
Please login below to download this issue (PDF)